A new study has uncovered unsafe prescribing practices promoted by some instant prescription service apps in Australia.
Done by researchers from the University of Western Australia, the study assessed the adherence to safety standards of seven prescription request apps available around the country.
FINDINGS
The findings, published in the Pharmacy journal of the Multidisciplinary Digital...
California-based Rune Labs, a precision neurology software and data platform company, is partnering with BlueRock Therapeutics, a clinical-stage biopharmaceutical company and subsidiary of Bayer AG, to aid in studying Parkinson's disease.
BlueRock will utilize Rune Labs' clinical development platform, StriveStudy, for clinical trial enrollment, real-world evidence data generation and monitoring...
Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology.
Pfizer will leverage Tempus' library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus' AI-driven companion diagnostic offerings...
Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of its second startup, DenovAI.
DenovAI will develop an AI-enabled computational biophysics platform that can discover potential antibodies directed toward specific epitopes (the part of an antigen molecule recognized by the immune system to which an antibody attaches...
Copenhagen-based digital health company Dawn Health announced a strategic partnership with pharma giant Novartis to develop a chronic condition management platform.
Under the collaboration, Dawn and Novartis will build remote monitoring and management tools for chronic conditions where they see an unmet need and concerns around disease progression, like multiple sclerosis, hypertension,...
Deidentifying data from wearable devices may not be enough to protect users' privacy, according to a review of studies published in the Lancet Digital Health.
The analysis focused on studies that evaluated whether individuals could be reidentified based on biometric signals from wearables. The researchers included 72 studies in their final review. Most focused on using EEG, ECG and inertial...
Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with diabetes and chronic disease management company Diathrive Health to provide lower-cost prescription medication and diabetes testing supplies to Diathrive's members.
Diathrive Health offers individuals and employers personalized coaching via live messaging and video chat, as well as care plans, articles and videos to help manage...
The Digital Medicine Society (DiMe) and a suite of digital health and pharma players partnered to launch a toolkit aimed at improving diversity, equity and inclusion in clinical trials.
The resources include a guide to each step of a digital clinical trial, shared definitions of terms like "diversity" and "equity," a list of different digital tools that could be used and the potential benefits...
Faro Health, which offers software to help researchers design clinical trials, announced last week it had raised $20 million in a round led by General Catalyst.
Participants in the raise include returning investors Section 32, Polaris Partners, Zetta Ventures, and Northpond Ventures. The startup previously scooped up $15 million in Series A funding.
"Faro has developed software that allows rapid...
Tech-enabled clinical trial platform Paradigm announced its launch alongside a $203 million Series A funding round co-led by ARCH Venture Partners and General Catalyst.
F-Prime Capital, LUX Capital, GV, Magnetic Ventures and Mubadala Capital also participated in the round. American Cancer Society's BrightEdge fund was a strategic investor.
The company also announced its acquisition of Deep Lens...